Men with inflammatory bowel disease have a four to five times higher risk of being diagnosed with prostate cancer, reports a 20-year US study.
This is the first report to show men with inflammatory bowel disease have higher than average PSA (prostate-specific antigen) values, and a significantly higher risk of prostate cancer.
Lead study author Dr. Shilajit Kundu said: “These patients may need to be screened more carefully than a man without inflammatory bowel disease.
Researchers looked at 1,033 men with inflammatory bowel disease and a control group of 9,306 men without the disease.
They followed the two groups of men for 18 years and found those with inflammatory bowel disease were much more likely to have prostate cancer and higher PSA levels.
